Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis M Ruilope

Showing results (21-30 of 456) with videos related to

Pageof 46
Sort By:
Nature Reviews. Nephrology|February 15, 2012
Diabetes: Glycemic and blood-pressure control--lower is not betterLuis M Ruilope
Journal of Clinical Hypertension (Greenwich, Conn.)|September 24, 2015
Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With DiabetesLuis M Ruilope,
Vascular Health and Risk Management|April 2, 2009
Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertensionLuis M Ruilope
Current Hypertension Reports|July 8, 2003
Lessons from trials in hypertensive type 2 diabetic patientsLuis M Ruilope
Cardiovascular Drugs and Therapy|September 17, 2003
Recent developments in the treatment of type 2 diabetes mellitusLuis M Ruilope
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2004
New European guidelines for management of hypertension: what is relevant for the nephrologistLuis M Ruilope
Current Medical Research and Opinion|July 2, 2011
Telmisartan for the management of patients at high cardiovascular riskLuis M Ruilope
Nature Reviews. Nephrology|December 22, 2009
The Framingham risk score is valuable in EuropeansLuis M Ruilope
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 5, 2008
New ADVANCEs in guidelinesLuis M Ruilope
Journal of the American Society of Nephrology : JASN|December 6, 2002
The kidney as a sensor of cardiovascular risk in essential hypertensionLuis M Ruilope
Pageof 46

Showing results (21-30 of 456) with videos related to

Sort By:
Pageof 46
Nature Reviews. Nephrology|February 15, 2012
Diabetes: Glycemic and blood-pressure control--lower is not betterLuis M Ruilope
Journal of Clinical Hypertension (Greenwich, Conn.)|September 24, 2015
Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With DiabetesLuis M Ruilope,
Vascular Health and Risk Management|April 2, 2009
Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertensionLuis M Ruilope
Current Hypertension Reports|July 8, 2003
Lessons from trials in hypertensive type 2 diabetic patientsLuis M Ruilope
Cardiovascular Drugs and Therapy|September 17, 2003
Recent developments in the treatment of type 2 diabetes mellitusLuis M Ruilope
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2004
New European guidelines for management of hypertension: what is relevant for the nephrologistLuis M Ruilope
Current Medical Research and Opinion|July 2, 2011
Telmisartan for the management of patients at high cardiovascular riskLuis M Ruilope
Nature Reviews. Nephrology|December 22, 2009
The Framingham risk score is valuable in EuropeansLuis M Ruilope
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 5, 2008
New ADVANCEs in guidelinesLuis M Ruilope
Journal of the American Society of Nephrology : JASN|December 6, 2002
The kidney as a sensor of cardiovascular risk in essential hypertensionLuis M Ruilope
Pageof 46